Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Abstract Immune checkpoint inhibitor (ICI) therapies effectively treat a broadening spectrum of cancer entities but induce various immune-related side effects (irAEs). Recent reports suggest a correlation between ICI-induced systemic inflammation and thromboembolic events as well as an increased eff...
Saved in:
Main Authors: | Malte Beckmann, Julian Schlüter, Michael Erdmann, Rafaela Kramer, Sarah Cunningham, Holger Hackstein, Robert Zimmermann, Lucie Heinzerling |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-11-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-024-03850-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol
by: Pedro-Antonio Regidor, et al.
Published: (2025-12-01) -
The diagnosis of DIC: a current overview
by: Hongyu Yang, et al.
Published: (2025-01-01) -
Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
by: Tobias Max Philipp Hartwich, et al.
Published: (2024-09-01) -
Viscoelastic Study of Hemostasis Disorders Associated with <i>Echis ocellatus</i> Envenoming in North Benin Using a Quantra Analyzer
by: Sébastien Larréché, et al.
Published: (2024-12-01) -
BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01)